You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 3
  • 180 Real-world treatment patterns and outcomes with first-line maintenance olaparib for BRCAm advanced ovarian cancer: a pan-European study (OVAL-1)

Article info

Article menu

Download PDFPDF

Ovarian cancer
180 Real-world treatment patterns and outcomes with first-line maintenance olaparib for BRCAm advanced ovarian cancer: a pan-European study (OVAL-1)
Free

Authors

Citation

Gourley C, Asselain B, Garbay D, et al
180 Real-world treatment patterns and outcomes with first-line maintenance olaparib for BRCAm advanced ovarian cancer: a pan-European study (OVAL-1)
International Journal of Gynecologic Cancer 2021;31:A204-A205.

Publication history

  • First published October 12, 2021.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.